Research Study Investigating How Well Semaglutide Works in People With Type 2 Diabetes Suffering From Overweight or Obesity

Inclusion Criteria:

• Male or female, age greater than or equal to 18 years at the time of signing informedconsent
• Body Mass Index (BMI) greater than or equal to 27 kg/m^2 '
• History of at least one self-reported unsuccessful dietary effort to lose body weight
• Diagnosed with type 2 diabetes (haemoglobin A1c 7-10% (53-86 mmol/mol) (bothinclusive)) 180 days or longer prior to the day of screening

Exclusion Criteria:

• A self-reported change in body weight greater than 5 kg (11 lbs) within 90 days beforescreening irrespective of medical records
• Renal impairment measured as estimated Glomerular Filtration Rate (eGFR) value of lessthan 30 mL/min/1.73 m^2 (less than 60 ml/min/1.73 m^2 in subjects treated withSodium-glucose Cotransporter 2 Inhibitors) according to chronic kidney disease (CKD)-Epidemiology Collaboration (EPI) creatinine equation as defined by KidneyDisease: Improving Global Outcomes (KDIGO) 2012 by the central laboratory at screening
• Uncontrolled and potentially unstable diabetic retinopathy or maculopathy. Verified bya pharmacologically pupil-dilated fundus examination performed by an ophthalmologistor an equally qualified health care provider (e.g. optometrist) within the past 90days prior to screening or in the period between screening and randomisation